Comparison of the 'iROC' trial participants to patients with bladder cancer in the United States undergoing radical cystectomy

BJU Int. 2023 Apr;131(4):439-442. doi: 10.1111/bju.15954. Epub 2023 Jan 9.

Authors

Daniel S Roberson¹, Leilei Xia^{1

2}, Daniel J Lee^{1

2}, Phillip M Pierorazio¹, S Bruce Malkowicz¹, Ronac Mamtani³, Thomas J Guzzo¹, Trinity J Bivalacqua¹

Affiliations

¹ Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
² Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
³ Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA, USA.

PMID: 36546841
DOI: 10.1111/bju.15954

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Cystectomy*
Humans
Retrospective Studies
Treatment Outcome
United States / epidemiology
Urinary Bladder
Urinary Bladder Neoplasms* / surgery